Melanoma, a form of skin cancer, is especially lethal when it metastasizes to other areas of the body. About half of melanomas have a mutation in the BRAF gene, and VICC investigators were instrumental in testing a new drug, which turned out to be a potent inhibitor of a mutated form of BRAF called V600E. […]
In March 2011, VICC launched the nation’s first personalized cancer decision support tool, “My Cancer Genome,” to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients. This Web-based information tool is designed to quickly educate clinicians on the rapidly expanding list of genetic […]
More than 1 million cancer deaths have been avoided in the last 20 years, according to the American Cancer Society. Thousands of patients come to Vanderbilt-Ingram Cancer Center for care each year and many are part of that 1 million, experiencing life after cancer. That can mean life events as big as a new baby […]
As a sports-crazy 14-year-old, Matt Bulow had his leg amputated below the knee. After Paralympics bronze medals and a world record in long jump, he is now helping others reach their mobility goals as a prosthetist.
Administrator Susan Mills manages the mountains of paperwork generated by VICC’s programs and grants.
Kim Brewer is off and running after two treatments for bladder cancer, which often recurs, making it the most expensive cancer to treat.
